Stock Market & Financial Investment News

News Breaks October 16, 2012 05:56 EDT MDCO The Medicines Co. upgraded to Buy from Hold at Jefferies Jefferies upgraded The Medicines Co. citing an attractive risk/reward profile ahead of the PHOENIX topline data in percutaneous coronary intervention expected in early 2013. The firm raised its price target for shares to $34 from $24. News For MDCO From The Last 14 Days Check below for free stories on MDCO the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 6, 2013 07:34 EDT MDCO Conference Forum to host a summit Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.